Staff Reports
What Do Drug Monopolies Cost Consumers in Developing Countries?
2014   December 2011  Number 530
JEL classification: D4, F13, L1, L65, O34

Author: Rebecca Hellerstein

This paper quantifies the effects of drug monopolies and low per-capita income on pharmaceutical prices in developing economies using the example of the antiretroviral drugs (ARVs) used to treat HIV.

Available only in PDF pdf  11 pages / 141 kb
Tools
E-mail Alerts